141 related articles for article (PubMed ID: 23393329)
1. Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells.
Hao Q; McKenzie R; Gan H; Tang H
Anticancer Res; 2013 Feb; 33(2):393-9. PubMed ID: 23393329
[TBL] [Abstract][Full Text] [Related]
2. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells.
Yuan J; Rozengurt E
J Cell Biochem; 2008 Feb; 103(2):648-62. PubMed ID: 17570131
[TBL] [Abstract][Full Text] [Related]
3. Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.
Durand N; Borges S; Storz P
Cell Mol Life Sci; 2015 Nov; 72(22):4369-82. PubMed ID: 26253275
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.
Liu Y; Li J; Ma Z; Zhang J; Wang Y; Yu Z; Lin X; Xu Z; Su Q; An L; Zhou Y; Ma X; Yang Y; Wang F; Chen Q; Zhang Y; Wang J; Zheng H; Shi A; Yu S; Zhang J; Zhao W; Chen L
Cancer Med; 2019 Feb; 8(2):729-741. PubMed ID: 30652415
[TBL] [Abstract][Full Text] [Related]
6. Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
Köster F; Engel JB; Schally AV; Hönig A; Schröer A; Seitz S; Hohla F; Ortmann O; Diedrich K; Buchholz S
Breast Cancer Res Treat; 2009 Jul; 116(2):273-9. PubMed ID: 18629632
[TBL] [Abstract][Full Text] [Related]
7. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway.
Pan H; Zhou W; He W; Liu X; Ding Q; Ling L; Zha X; Wang S
Int J Mol Med; 2012 Aug; 30(2):337-43. PubMed ID: 22580499
[TBL] [Abstract][Full Text] [Related]
8. Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K+ channel.
Lee GW; Park HS; Kim EJ; Cho YW; Kim GT; Mun YJ; Choi EJ; Lee JS; Han J; Kang D
Acta Physiol (Oxf); 2012 Apr; 204(4):513-24. PubMed ID: 21910834
[TBL] [Abstract][Full Text] [Related]
9. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
10. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase D3 activation and phosphorylation by signaling through G alpha q.
Yuan J; Rey O; Rozengurt E
Biochem Biophys Res Commun; 2005 Sep; 335(2):270-6. PubMed ID: 16081049
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
13. Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes.
Ryvkin V; Rashel M; Gaddapara T; Ghazizadeh S
J Biol Chem; 2015 Apr; 290(17):11199-208. PubMed ID: 25802335
[TBL] [Abstract][Full Text] [Related]
14. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours.
Azoitei N; Pusapati GV; Kleger A; Möller P; Küfer R; Genze F; Wagner M; van Lint J; Carmeliet P; Adler G; Seufferlein T
Gut; 2010 Oct; 59(10):1316-30. PubMed ID: 20732914
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of PKD1 and PKD2 in gastric cancer and analysis of PKD1 and PKD2 function in the model system.
Shabelnik MY; Kovalevska LM; Yurchenko MY; Shlapatska LM; Rzepetsky Y; Sidorenko SP
Exp Oncol; 2011 Dec; 33(4):206-11. PubMed ID: 22217708
[TBL] [Abstract][Full Text] [Related]
17. Jun amino-terminal kinase 1 activation promotes cell survival in ErbB2-positive breast cancer.
Han JS; Crowe DL
Anticancer Res; 2010 Sep; 30(9):3407-12. PubMed ID: 20944115
[TBL] [Abstract][Full Text] [Related]
18. PKD at the crossroads of DAG and PKC signaling.
Wang QJ
Trends Pharmacol Sci; 2006 Jun; 27(6):317-23. PubMed ID: 16678913
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cδ mediates the activation of protein kinase D2 in platelets.
Bhavanasi D; Kim S; Goldfinger LE; Kunapuli SP
Biochem Pharmacol; 2011 Oct; 82(7):720-7. PubMed ID: 21736870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]